Corvus Pharmaceuticals CRVS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.69M-11.1% | -$12.32M-21.3% | -$10.16M-27.0% | -$8M-153% | $15.19M+225% | ||
| $29K+11.5% | $26K-7.1% | $28K-3.4% | $29K+31.8% | $22K+10.0% | ||
| $2.65M+68.4% | $1.57M+26.0% | $1.25M-0.6% | $1.26M+0.4% | $1.25M+53.9% | ||
| -$10.37M-12.9% | -$9.19M+3.9% | -$9.57M-65.6% | -$5.78M+30.1% | -$8.26M+2.4% | ||
| $91K+264% | $25K— | $0-100% | $113K+214% | $36K— | ||
| -$144.85M— | —— | -$2.62M+87.1% | -$20.3M-578% | $4.24M+170% | ||
| $190.75M+953,630% | $20K-94.4% | $360K-99.0% | $35.77M+12,721% | $279K-98.5% | ||
| $35.53M— | —— | -$11.82M-222% | $9.69M+359% | -$3.74M— | ||
| -$10.47M-13.6% | -$9.22M+3.7% | -$9.57M-62.4% | -$5.89M+29.0% | -$8.3M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Corvus Pharmaceuticals generate?
- Corvus Pharmaceuticals (CRVS) generated -$34.9M in operating cash flow over the trailing twelve months.
- What is Corvus Pharmaceuticals's free cash flow?
- After $229.0K of capital expenditures, Corvus Pharmaceuticals's free cash flow was -$35.1M over the trailing twelve months, down 45.7% year over year.
- Where does Corvus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Corvus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.